Showing results (141-150 of 31,336) with videos related to
Sort By:
Pageof 3,134
Journal of Medicinal Chemistry|August 19, 2010
Toward development of targeted nonsteroidal antiandrogen-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid-gadolinium complex for prostate cancer diagnosticsHanit Marom, Keren Miller, Yossi Bechor-Bar, et al.Journal of Medicinal Chemistry|August 20, 2010
Inhibition of mycobacterial replication by pyrimidines possessing various C-5 functionalities and related 2'-deoxynucleoside analogues using in vitro and in vivo modelsNaveen C Srivastav, Dinesh Rai, Christopher Tse, et al.Journal of Medicinal Chemistry|August 18, 2010
Discovery of pyridazinopyridinones as potent and selective p38 mitogen-activated protein kinase inhibitorsBin Wu, Hui-Ling Wang, Liping Pettus, et al.Journal of Medicinal Chemistry|August 6, 2010
Novel carbamates as orally active acetylcholinesterase inhibitors found to improve scopolamine-induced cognition impairment: pharmacophore-based virtual screening, synthesis, and pharmacologyShailendra S Chaudhaery, Kuldeep K Roy, Neeraj Shakya, et al.Journal of Medicinal Chemistry|August 6, 2010
Identification of orally available naphthyridine protein kinase D inhibitorsErik L Meredith, Ophelia Ardayfio, Kimberly Beattie, et al.Journal of Medicinal Chemistry|August 6, 2010
A novel water-soluble gossypol derivative increases chemotherapeutic sensitivity and promotes growth inhibition in colon cancerFei Yan, Xing-Xin Cao, Hai-Xia Jiang, et al.Journal of Medicinal Chemistry|August 6, 2010
Development and characterization of new inhibitors of the human and mouse hematopoietic prostaglandin D(2) synthasesAngelika N Christ, Larisa Labzin, Gregory T Bourne, et al.Journal of Medicinal Chemistry|August 6, 2010
Tetrahydroisoquinoline derivatives as highly selective and potent Rho kinase inhibitorsXingang Fang, Yan Yin, Yen Ting Chen, et al.Journal of Medicinal Chemistry|August 6, 2010
Replacement of imidazolyl by pyridyl in biphenylmethylenes results in selective CYP17 and dual CYP17/CYP11B1 inhibitors for the treatment of prostate cancerQingzhong Hu, Carsten Jagusch, Ulrike E Hille, et al.Journal of Medicinal Chemistry|August 6, 2010
Design of potent inhibitors of human RAD51 recombinase based on BRC motifs of BRCA2 protein: modeling and experimental validation of a chimera peptideJulian Nomme, Axelle Renodon-Cornière, Yuya Asanomi, et al.Pageof 3,134